Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Dartmouth bioengineers develop humanized yeast

29.08.2003


Bioengineers at Dartmouth have genetically engineered yeast to produce humanized therapeutic proteins to address the manufacturing crunch currently confronting the biopharmaceutical industry. Reported in this week’s issue of Science, the researchers have re-engineered the yeast P. pastoris to secrete a complex human glycoprotein--a process offering significant advantages over current production methods using mammalian cell lines, according to the researchers.

The study, titled "Production of Complex Human Glycoproteins in Yeast," is one result of a collaboration between researchers at Dartmouth’s Thayer School of Engineering and GlycoFi, Inc., a biotech company located in Lebanon, New Hampshire. Founded in the spring of 2000 by Dartmouth engineering professors Tillman Gerngross and Charles Hutchinson, GlycoFi is advancing technology for the production of humanized proteins using fungal-based expression systems.

"For the first time, we have shown that yeast can be used to produce a complex human glycoprotein," says Professor Gerngross. "This technology has the potential to revolutionize the way therapeutic proteins are made--better, cheaper, faster, safer--and offer a level of control over the quality of the end product that has never existed before."



Proteins for pharmaceuticals must be manufactured by living cells. These cells are genetically engineered to produce (or express) proteins that mimic the ones synthesized by humans. These proteins can then be used to treat diseases ranging from cancer and multiple sclerosis to hemophelia and renal disease.

Current production of these therapeutic proteins, however, is limited by capacity due to rapid growth in the discovery of protein-based therapies--to the point that some approved drugs cannot be produced in adequate amounts, and still others are not making it into commercialization due to cost-prohibitive production methods.

"This development is very timely considering the production capacity bottleneck that’s facing today’s biomanufacturing industry," notes Hutchinson, CEO of GlycoFi and Dean Emeritus of Thayer School.

The Dartmouth researchers genetically engineered the yeast P. pastoris to perform a series of sequential reactions (pathways) that mimic the processing of proteins in humans. After eliminating non-human pathways from the yeast, five genes were inserted causing the yeast to construct a new secretion pathway that synthesizes human-like glycoprotein structures of superior quality.

"The protein structures we are seeing in our yeast are of a purity and uniformity unprecedented in biopharmaceutical manufacturing," said Stefan Wildt, Director of Strain Devlopment at GlycoFi, and one of the authors of the paper. "This makes it possible to harness both the inherent advantages of fungal protein expression systems and the potential to significantly increase pharmaceutical production capacities, therefore ultimately improving patient access to life-saving drug therapies."

Sue Knapp | EurekAlert!
Further information:
http://www.dartmouth.edu/

More articles from Life Sciences:

nachricht 'Y' a protein unicorn might matter in glaucoma
23.10.2017 | Georgia Institute of Technology

nachricht Microfluidics probe 'cholesterol' of the oil industry
23.10.2017 | Rice University

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Salmonella as a tumour medication

HZI researchers developed a bacterial strain that can be used in cancer therapy

Salmonellae are dangerous pathogens that enter the body via contaminated food and can cause severe infections. But these bacteria are also known to target...

Im Focus: Neutron star merger directly observed for the first time

University of Maryland researchers contribute to historic detection of gravitational waves and light created by event

On August 17, 2017, at 12:41:04 UTC, scientists made the first direct observation of a merger between two neutron stars--the dense, collapsed cores that remain...

Im Focus: Breaking: the first light from two neutron stars merging

Seven new papers describe the first-ever detection of light from a gravitational wave source. The event, caused by two neutron stars colliding and merging together, was dubbed GW170817 because it sent ripples through space-time that reached Earth on 2017 August 17. Around the world, hundreds of excited astronomers mobilized quickly and were able to observe the event using numerous telescopes, providing a wealth of new data.

Previous detections of gravitational waves have all involved the merger of two black holes, a feat that won the 2017 Nobel Prize in Physics earlier this month....

Im Focus: Smart sensors for efficient processes

Material defects in end products can quickly result in failures in many areas of industry, and have a massive impact on the safe use of their products. This is why, in the field of quality assurance, intelligent, nondestructive sensor systems play a key role. They allow testing components and parts in a rapid and cost-efficient manner without destroying the actual product or changing its surface. Experts from the Fraunhofer IZFP in Saarbrücken will be presenting two exhibits at the Blechexpo in Stuttgart from 7–10 November 2017 that allow fast, reliable, and automated characterization of materials and detection of defects (Hall 5, Booth 5306).

When quality testing uses time-consuming destructive test methods, it can result in enormous costs due to damaging or destroying the products. And given that...

Im Focus: Cold molecules on collision course

Using a new cooling technique MPQ scientists succeed at observing collisions in a dense beam of cold and slow dipolar molecules.

How do chemical reactions proceed at extremely low temperatures? The answer requires the investigation of molecular samples that are cold, dense, and slow at...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

3rd Symposium on Driving Simulation

23.10.2017 | Event News

ASEAN Member States discuss the future role of renewable energy

17.10.2017 | Event News

World Health Summit 2017: International experts set the course for the future of Global Health

10.10.2017 | Event News

 
Latest News

Microfluidics probe 'cholesterol' of the oil industry

23.10.2017 | Life Sciences

Gamma rays will reach beyond the limits of light

23.10.2017 | Physics and Astronomy

The end of pneumonia? New vaccine offers hope

23.10.2017 | Health and Medicine

VideoLinks
B2B-VideoLinks
More VideoLinks >>>